SELLAS Life Sciences Group, Inc. — Director's Dealing 2015

Jun 24, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2015-06-19

Reporting Person: GALLIKER STEPHEN S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-19	Stock Option (right to buy)	$1.77	A	100000	Acquired	2025-06-19	Common Stock (100000)	Direct

Footnotes

F1: The Issuer's Board of Directors approved the stock option grant on April 17, 2015, subject to stockholder approval of an amendment to the Amended and Restated 2007 Incentive Plan of the Issuer (the "Plan") to increase the number of shares of common stock available under the Plan. The Issuer's stockholders approved such amendment on June 19, 2015.

F2: The stock option vests in four equal quarterly installments over a period of one year beginning three months after June 19, 2015.